Cell transplants at U of M could provide diabetes cure

Star Tribune – “After more than three decades of research a consortium of schools that includes the U has completed testing on the transplant technique. Now, the U is preparing to apply to the U.S. Food and Drug Administration for a license to become a manufacturing facility. University officials say a ‘biological drug license’ would allow them to commercialize the new treatment, which has cost the U at least $25 million in grants and donations so far. That, they say, would represent a unique example of a university bringing a new treatment directly from academic research to human applications without any company funding. ‘That is completely and entirely unheard of,’ said Dr. Bernhard J. Hering, who directs the project at the U. If the FDA approves, Hering said, a doctor will be able to prescribe human islets instead of insulin injections. Somewhere between 60 and 70 percent of patients who receive the cells could expect to remain insulin-free after five years, Hering said.”

The article also follows several people who have benefited from the transplant, and shares some of their firsthand accounts of what life has been like for them post-treatment. To read the full article and learn more about their stories, click here.

Post a Comment

Your email is never shared. Required fields are marked *